Trial intelligence / Profile preview

Azithromycin versus benzathine benzylpenicillin for treatment of yaws

PACTR201306000520103Completed

Sponsor
University of Ghana
Start
Feb 2011
Modality
Small Molecules
Countries
1
01

Overview

Randomised, open-label trial in yaws comparing Single-dose oral azithromycin with Injectable benzathine benzylpenicillin (2 arms). Primary endpoint: Cure at 6 months. Started Feb 2011; status: completed.

02

Drugs

azithromycinbenzylpenicillin
03

Conditions

yaws

Beyond the preview

Go deeper on PACTR201306000520103.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on PACTR201306000520103.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call